Katia Do Nascimento Couceiro

Katia Do Nascimento Couceiro

Auto-generated profile, based on publicly available information

Katia Do Nascimento Couceiro

Universidade do Estado do Amazonas, Brasil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
ABAndreza Karoline Souza Barros de Brito
Andreza Karoline Souza Barros de Brito
DSDébora Raysa Teixeira de Sousa
Débora Raysa Teixeira de Sousa
EJEdson Fidelis da Silva Junior
Edson Fidelis da Silva Junior
HRHelton Jardys da Silva Ruiz
Helton Jardys da Silva Ruiz
AAAna Ruth Arcanjo
Ana Ruth Arcanjo
MGMaria das Graças Vale Barbosa Guerra
Maria das Graças Vale Barbosa Guerra
Chagas disease is gaining importance in the Brazilian Amazon region as a differential diagnosis of febrile syndrome. The most recent microoutbreak occurred in Ipixuna, in Amazonas state. An epidemiological survey was conducted using parasitological and serological tests, and electrocardiographic analysis. The patients belonged to one family and had ingested açaí acquired from Ipixuna. All patients reported fever and initially a thick blood smear test was done to identify Trypanosoma cruzi. Benznidazole treatment was administered to all patients. Knowledge of the epidemiological dynamics of Chagas disease allows us to improve control and management measures for this disease.

22 June 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
KCKatia Do Nascimento Couceiro
Katia Do Nascimento Couceiro
JOJessica Vanina Ortiz
Jessica Vanina Ortiz
MSMônica Regina Hosannah da Silva e Silva
Mônica Regina Hosannah da Silva e Silva
DSDébora Raysa Teixeira de Sousa
Débora Raysa Teixeira de Sousa
RARubens Celso AndradeJr
Rubens Celso AndradeJr
JGJorge Augusto de Oliveira Guerra
Jorge Augusto de Oliveira Guerra
Background: Chagas disease is a neglected tropical disease that is still considered a global health emergency. In the Amazon region, most of the reports are of acute cases that are associated with oral transmission. This study aimed to evaluate myocardial injury in patients with acute Chagas disease before and after treatment. Methods and Results: We evaluated 23 patients with acute Chagas disease in 3 different stages of progression. Group 1 had 12 patients evaluated during the acute phase, at the time of diagnosis, and 1 year after treatment, and Group 2 had 11 patients in the late postacute phase who were evaluated 5.2 years on average after diagnosis and treatment. ECGs with the Selvester score, 24‐hour Holter exam, and cardiovascular magnetic resonance imaging were performed. The mean age of the 23 patients was 44.3±18.9 years, and they were mostly men (15/65.24%) from Amazonas state (22/95.6%). In 69.6% (n=16) of the patients, some ECG alterations were found, the most frequent being left anterior fascicular block and ventricular repolarization. In Group 1, the 24‐hour Holter exam showed atrial tachycardia in 3 (25%) patients and ventricular extrasystoles in 2 (16.7%) patients. In Group 2, 1 patient had ventricular extrasystoles. Myocardial injury was observed in 7 patients (58.3%) at the acute phase and in 5 (50%) patients at the 1‐year follow‐up in Group 1 and in 2 (18.2%) patients in Group 2. Conclusions: This article describes, for the first time, myocardial injury shown by cardiovascular magnetic resonance imaging in a group of patients with acute Chagas disease and reveals the importance of early detection and follow‐up of the cardiac impairment in these patients.

29 April 2021 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
KCKatia Do Nascimento Couceiro
Katia Do Nascimento Couceiro
JOJessica Vanina Ortiz
Jessica Vanina Ortiz
MCMichael Do Nascimento Correia
Michael Do Nascimento Correia
MSMônica Regina Hosannah da Silva e Silva
Mônica Regina Hosannah da Silva e Silva
ABAlba Regina Brandão
Alba Regina Brandão
JGJorge Augusto de Oliveira Guerra
Jorge Augusto de Oliveira Guerra
Background: In the Brazilian Amazon, a new epidemiological profile of Chagas disease transmission, the oral route, has been detected and cited as being responsible for the increase in acute cases in Brazil. The clinical evaluation of acute Chagas disease (ACD) has been a challenge since it can progress to a chronic phase with cardiac alterations, and the follow-up by modern diagnostic methods is very difficult due to the socio-geographical characteristics of the Brazilian Amazon. Thus, alternatives should be sought to alleviate this problem. We conducted a study to evaluate subjects with ACD using the 12-lead ECG QRS score (Selvester score) as an estimative of myocardial injury progression before and after ACD treatment. Methods: The study included indigenous subjects from the Amazon region with ACD in clinical follow-up at the Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD) Chagas Disease outpatient clinic in the state of Amazonas, Brazil. The control group consisted of 31 healthy volunteers with no history of heart disease and no reactive serology for Chagas disease. Baseline ECG was performed in all subjects. The Selvester scoring method was performed according to the standardized guide (< 3 points: no myocardial injury,> 3: points × 3% = % of the predicted LV infarction). Results: A total of 62 subjects were included, 31 as cases and 31 as controls. The mean follow-up of the case group was 17 months. The control group presented normal ECG. The case group presented 13 alterations before treatment and 11 after. Nineteen individuals presented scores > 3 points, 6 before and 13 after. In 19.36% of subjects, myocardial injury was found before treatment and in 41.94% after treatment. Conclusion: This is the first study that uses the Selvester score (SS) to predict myocardial injury in subjects with ACD. The results of this study suggest the significant presence of myocardial injury from the beginning of treatment to the period post treatment of ACD, which demonstrates that the SS can be applied for stratification and follow-up of Chagas disease in the Amazon region.

1 January 2023 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
ZVZanair Soares Vasconcelos
Zanair Soares Vasconcelos
HSHany Abdulateif Salem
Hany Abdulateif Salem
SVSâmia Pimenta Veiga
Sâmia Pimenta Veiga
FLFabiola Estefany Botelho de Lima
Fabiola Estefany Botelho de Lima
CGCésar Rogério da Silva Gonçalves
César Rogério da Silva Gonçalves
MGMaria das Graças Vale Barbosa Guerra
Maria das Graças Vale Barbosa Guerra
Immunogenicity has emerged as a challenge in the development of vaccines against coronavirus disease of 2019 (COVID-19). Immunogenicity is a determinant of the efficacy and safety of vaccines. This systematic review and associated meta-analysis summarized and characterized the immunogenicity of COVID-19 vaccines in randomized controlled trials (RCTs). Relevant RCTs were systematically sourced from different medical databases in August 2021. The risk ratios and mean differences with 95% confidence intervals were calculated. Of 2,310 papers, 16 RCTs were eligible for review. These RCTs involved a total of 26,698 participants (15,292 males and 11,231 females). The pooled results showed a significant difference in the geometric mean titer between the vaccinated and control groups in favor of the vaccine group after 1 and 2 months of follow-up, for the young age group (18 - < 55y), and with different doses (P < 0.001). The difference in the older age group (>55y) was insignificant (P = 0.24). The seroconversion rate of spike neutralizing antibodies favored the vaccine groups 1 or 2 months after vaccination (P < 0.001). The seroconversion rate of the vaccine group was significantly different (P < 0.001) from that of the control group. Vaccination elicits immunogenicity in the follow-up period for all age groups and at low and large doses. Therefore, people should be encouraged to receive vaccines currently being offered. A boost dose has been asserted for the elderly.

4 June 2025 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
PDF file
SSSusan Smith-Doria
Susan Smith-Doria
LMLaise Kelma Costa Magalhães
Laise Kelma Costa Magalhães
LMLaylah Kelre Costa Magalhães
Laylah Kelre Costa Magalhães
SPSuzane Ribeiro Prestes
Suzane Ribeiro Prestes
ABAlba Regina Jorge Brandão
Alba Regina Jorge Brandão
MGMaria das Graças Vale Barbosa Guerra
Maria das Graças Vale Barbosa Guerra
: The prevalence and characteristics of chronic Chagas disease (CCD) in the Amazon Region remain underexplored. This study aimed to describe the challenges encountered during a serological survey and follow-up of CCD, while also highlighting potential risk factors in the Amazon Region. The serological survey involved residents of periurban and rural areas of Manaus in the Brazilian Amazon. All participants were invited to complete a clinical, epidemiological, and demographic questionnaire and provide a blood sample for anti-Trypanosoma cruzi (T. cruzi) IgG tests. A total of 1,845 participants were included, of whom 43 were identified as having presumed CCD, based on having at least two positive serological tests. Only 35 underwent complementary tests, and five had cardiac alterations not consistent with CCD. The main risk factors associated with CCD were age ≥20 years, living in periurban areas, reporting the presence of the insect vector inside the household, entering the forest, consumption of bushmeat, and having undergone blood transfusion. In the Amazon, the population is exposed to the sylvatic T. cruzi life cycle and is unaware of the associated risk factors. The divergent serology results raise doubts about the reliability of the commercial serological tests used for CCD screening in the region. Surveillance for CCD is important in the Amazon.

7 October 2021 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
JOJessica Vanina Ortiz
Jessica Vanina Ortiz
KCKatia Do Nascimento Couceiro
Katia Do Nascimento Couceiro
SDSusan Smith Doria
Susan Smith Doria
DSDébora Raysa Teixeira de Sousa
Débora Raysa Teixeira de Sousa
HSHenrique Manuel Condinho da Silveira
Henrique Manuel Condinho da Silveira
JFJoão Marcos Bemfica Barbosa Ferreira
João Marcos Bemfica Barbosa Ferreira
Introdução A doença de Chagas (DC) foi descoberta em 1909 pelo médico brasileiro Carlos Chagas, que descreveu o agente etiológico – um protozoário flagelado denominado Trypanossoma cruzi – suas características morfológicas e seu ciclo de vida e de transmissão, bem como manifestações clínicas da doença. Apesar de os insetos triatomíneos serem os vetores primários de transmissão da DC, a via oral por meio de alimentos contaminados foi considerada o meio principal de transmissão na Amazônia brasileira. A doença apresenta duas [...] Introdução A doença de Chagas (DC) foi descoberta em 1909 pelo médico brasileiro Carlos Chagas, que descreveu o agente etiológico – um protozoário flagelado denominado Trypanossoma cruzi – suas características morfológicas e seu ciclo de vida e de transmissão, bem como manifestações clínicas da doença. Apesar de os insetos triatomíneos serem os vetores primários de transmissão da DC, a via oral por meio de alimentos contaminados foi considerada o meio principal de transmissão na Amazônia brasileira. A doença apresenta duas